Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Tech Provides Insights Into the Pathogenesis of Psoriatic Arthritis

Maria de la Luz Garcia-Hernandez, PhD, & Christopher Ritchlin, MD, MPH  |  May 5, 2022

Also, unique environmental clues are critical for chemotaxis of immune cells to the synovial tissue. For example, CXCR3 expression by CD8 T cells and the local production of CXCR3 ligands (CXCL9, CXCL10) likely explain the considerable accumulation of CD8 T cells in the synovial tissue and fluid of PsA patients. Interestingly, tissue-resident CD8 T cell clusters express the skin/gut markers (ITGA1: CD49a), supporting their potential migration from the skin or gut to the synovium or, alternatively, moving from the synovium to the skin or gut (see Figure 1).29

The application of CyTOF and single-cell RNA sequence analysis identified three CD8 T cell subsets in PsA synovial fluid characterized by class II expression (human leukocyte antigen-DR [HLA-DR] low vs. high) and ZNF683—a gene classically expressed by tissue-resident memory T (TRM) cells.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The detection of proliferative markers like MK167 and STMN1 and the evidence of clonal expansion based on T cell receptor (TCR) α and ß sequencing in CD8 T cells provide evidence of local activation and suggest antigen-driven CD8 T cell activation and expansion inPsA synovial fluid. Also, expression of genes involved in the production of cytotoxic molecules (i.e., granzyme A, B, H and K) and chemokines (i.e., ccl4, ccl5) by HLA-DR high CD8 TRM cells was also identified.29

Thus, the findings generated from examination of synovial fluid reveal a predominant CD8 T cell response with clonal features and polyfunctional cells that release various cytokines critical for activation of stromal cells along with adaptive and innate immune cells in target tissue. Also, the capacity of CD8 T cells to produce chemokines facilitates recruitment of additional immune cells resulting in the amplification and persistence of local inflammation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Studies in our lab, currently focused on understanding the functional heterogeneity of CD8 T cells and their migratory and functional characteristics in PsA patients with a humanized murine model, may lead to strategies that modulate their pathogenic functions and alleviate skin and musculoskeletal inflammation.

The studies outlined above demonstrated a dominant CD8 cell response in the synovial fluid but these cells expressed few activation markers. In contrast, monocytes in PsA synovial fluid showed a prominent activation profile. CyTOF analysis showed that monocytes and macrophages in synovial fluid produced significant amounts of CCL2, which is likely responsible for recruiting inflammatory monocytes to the inflamed synovia and osteopontin, a matricellular protein with multiple functions including upregulation of IL-1ß and modulation of signaling and chemoattractant pathways in monocytes, fibroblasts and bone.30-32

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsPsoriatic Arthritis Tagged with:Psoriatic Arthritis

Related Articles

    Looking to Psoriatic Arthritis History to Disrupt Current Thinking

    May 4, 2022

    As the cloud moved away from the tent, Miriam’s skin suddenly became diseased, as white as snow. When Aaron turned toward her, he saw that she was diseased. —Numbers 12:10 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEFor 29 years he [Fray Pedro de Urraca] was afflicted by … pain, suffering it at once in all the joints…

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Psoriatic Arthritis: From Leeds to the Limelight

    August 1, 2009

    Advances in understanding of the disease begin in the 1960s

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences